Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Global X Genomics & Biotechnology ETF
(NQ:
GNOM
)
43.61
-1.39 (-3.09%)
Official Closing Price
Updated: 4:15 PM EDT, Mar 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,266
Open
44.69
Bid (Size)
21.95 (200)
Ask (Size)
44.45 (100)
Prev. Close
45.00
Today's Range
43.61 - 44.69
52wk Range
27.20 - 51.42
Shares Outstanding
33,418,720
Dividend Yield
2.71%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Is CRSP Stock Falling Pre-Market Today?
↗
March 10, 2026
The company plans to issue $350 million in convertible senior notes that are scheduled to mature in 2031.
Via
Stocktwits
Why Did BNTX Stock Tumble 17% Pre-Market Today?
↗
March 10, 2026
BioNTech co-founders Ugur Sahin and Özlem Türeci are set to leave the company to head the new venture.
Via
Stocktwits
Performance
YTD
-4.5%
-4.5%
1 Month
-5.9%
-5.9%
3 Month
-7.6%
-7.6%
6 Month
+17.3%
+17.3%
1 Year
+21.6%
+21.6%
More News
Read More
Moderna Stock Gains After FDA Accepts Company’s Revised Flu Vaccine Application For Review
↗
February 18, 2026
Via
Stocktwits
Qiagen Shares Rise Premarket As Preliminary Q1 Results, Hikes FY25 EPS Guidance
↗
April 07, 2025
Via
Benzinga
ETF Battles ARKG Vs. GNOM - What's The Better Genomic/Biotech Play?
↗
June 04, 2021
Via
Talk Markets
3 Gene Editing Stocks with Potential to Transform Medicine
↗
August 09, 2024
Via
InvestorPlace
The 3 Best Gene Editing Stocks to Buy in July 2024
↗
July 08, 2024
Via
InvestorPlace
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
↗
May 10, 2024
Via
InvestorPlace
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
↗
May 02, 2024
Via
InvestorPlace
3 Stocks That Could Be the Next Big Thing in Gene Editing
↗
March 21, 2024
Via
InvestorPlace
3 Gene Editing Stocks With Unprecedented Surge Potential
↗
February 13, 2024
Via
InvestorPlace
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential
↗
January 31, 2024
Via
InvestorPlace
3 Gene Editing Stocks to Generate Super-Charged Gains
↗
October 18, 2023
Via
InvestorPlace
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
↗
March 25, 2023
Via
InvestorPlace
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
↗
March 15, 2023
Via
InvestorPlace
3 Gene Editing Stocks With the Best Long-Term Potential
↗
January 25, 2023
Via
InvestorPlace
3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years
↗
January 18, 2023
Via
InvestorPlace
ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM
↗
October 21, 2021
Via
Talk Markets
A Comprehensive Guide To Genomic ETFs
↗
July 11, 2021
Via
Talk Markets
Top-Performing Biotech ETFs of Last Week
↗
June 14, 2021
Via
Talk Markets
Frequently Asked Questions
Is Global X Genomics & Biotechnology ETF publicly traded?
Yes, Global X Genomics & Biotechnology ETF is publicly traded.
What exchange does Global X Genomics & Biotechnology ETF trade on?
Global X Genomics & Biotechnology ETF trades on the Nasdaq Stock Market
What is the ticker symbol for Global X Genomics & Biotechnology ETF?
The ticker symbol for Global X Genomics & Biotechnology ETF is GNOM on the Nasdaq Stock Market
What is the current price of Global X Genomics & Biotechnology ETF?
The current price of Global X Genomics & Biotechnology ETF is 43.61
When was Global X Genomics & Biotechnology ETF last traded?
The last trade of Global X Genomics & Biotechnology ETF was at 03/12/26 04:15 PM ET
What is the market capitalization of Global X Genomics & Biotechnology ETF?
The market capitalization of Global X Genomics & Biotechnology ETF is 1.46B
How many shares of Global X Genomics & Biotechnology ETF are outstanding?
Global X Genomics & Biotechnology ETF has 1B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
